Gagliano T - Search Results

1

HDACs and the epigenetic plasticity of cancer cells: Target the complexity.

Brancolini C, Gagliano T, Minisini M. Brancolini C, et al. Among authors: gagliano t. Pharmacol Ther. 2022 Oct;238:108190. doi: 10.1016/j.pharmthera.2022.108190. Epub 2022 Apr 14. Pharmacol Ther. 2022. PMID: 35430294 Free article. Review.

2

Targeting histone deacetylases for combination therapies in neuroendocrine tumors.

Gagliano T, Brancolini C. Gagliano T, et al. Cancer Gene Ther. 2021 Jun;28(6):547-550. doi: 10.1038/s41417-020-00260-x. Epub 2020 Nov 21. Cancer Gene Ther. 2021. PMID: 33221822 Review. No abstract available.

3

Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9.

Brancolini C, Di Giorgio E, Formisano L, Gagliano T. Brancolini C, et al. Among authors: gagliano t. Life (Basel). 2021 Jan 27;11(2):90. doi: 10.3390/life11020090. Life (Basel). 2021. PMID: 33513699 Free PMC article. Review.

4

Epigenetic Mechanisms beyond Tumour-Stroma Crosstalk.

Gagliano T, Brancolini C. Gagliano T, et al. Cancers (Basel). 2021 Feb 22;13(4):914. doi: 10.3390/cancers13040914. Cancers (Basel). 2021. PMID: 33671588 Free PMC article. Review.

5

The multifaceted role of lemur tyrosine kinase 3 in health and disease.

Ditsiou A, Gagliano T, Samuels M, Vella V, Tolias C, Giamas G. Ditsiou A, et al. Among authors: gagliano t. Open Biol. 2021 Sep;11(9):210218. doi: 10.1098/rsob.210218. Epub 2021 Sep 29. Open Biol. 2021. PMID: 34582708 Free PMC article. Review.

6

Cancer gene therapy 2020: highlights from a challenging year.

Giamas G, Gagliano T. Giamas G, et al. Among authors: gagliano t. Cancer Gene Ther. 2022 Jan;29(1):1-3. doi: 10.1038/s41417-021-00340-6. Epub 2021 May 7. Cancer Gene Ther. 2022. PMID: 33963297 Free PMC article. No abstract available.

7

Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing.

Shah K, Gagliano T, Garland L, O'Hanlon T, Bortolotti D, Gentili V, Rizzo R, Giamas G, Dean M. Shah K, et al. Among authors: gagliano t. Oncogene. 2020 Sep;39(39):6172-6189. doi: 10.1038/s41388-020-01429-2. Epub 2020 Aug 20. Oncogene. 2020. PMID: 32820253 Free PMC article.

8

Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors.

Molè D, Gagliano T, Gentilin E, Tagliati F, Pasquali C, Ambrosio MR, Pansini G, Degli Uberti EC, Zatelli MC. Molè D, et al. Among authors: gagliano t. Endocr Relat Cancer. 2011 Jul 1;18(4):439-50. doi: 10.1530/ERC-11-0055. Print 2011 Aug. Endocr Relat Cancer. 2011. PMID: 21606156

9

Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling.

Simon T, Gagliano T, Giamas G. Simon T, et al. Among authors: gagliano t. Trends Mol Med. 2017 Mar;23(3):282-292. doi: 10.1016/j.molmed.2017.01.002. Epub 2017 Feb 2. Trends Mol Med. 2017. PMID: 28162910 Review.

10

LMTK3 confers chemo-resistance in breast cancer.

Stebbing J, Shah K, Lit LC, Gagliano T, Ditsiou A, Wang T, Wendler F, Simon T, Szabó KS, O'Hanlon T, Dean M, Roslani AC, Cheah SH, Lee SC, Giamas G. Stebbing J, et al. Among authors: gagliano t. Oncogene. 2018 Jun;37(23):3113-3130. doi: 10.1038/s41388-018-0197-0. Epub 2018 Mar 15. Oncogene. 2018. PMID: 29540829 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page